The prospect of Vietnam's Pharmaceutical industry in 2022 is assessed to be even brighter than last year

The global outbreak of the Covid-19 pandemic has made the whole world realize the paramount importance of healthcare and the healthcare industry in unprecedented ways. On the one hand, it highlights the important role the Pharmaceutical and innovative drugs industry plays in ensuring global safety and security. On the other hand, it also exposes gaps in the global economy, including in health care services.

Before the impact of the pandemic, the pharmaceutical industry faced many difficulties when the supply chain broke, the price of raw materials and transportation increased, the change of habits and the demand for drugs. Along with that is the Government's strict disease prevention and control regulations, people restricting access to disease treatment facilities, ... the pharmaceutical market has been severely stagnated. The survey results of ‘Vietnam Report’ conducted in November 2021 with pharmaceutical enterprises on the impact of Covid-19 on the pharmaceutical industry in 2021 showed that 57.14% of enterprises assessed that their business situation deteriorated a bit. little; 14.29% of enterprises assessed that their business situation was not affected and only 7.14% of enterprises rated their business situation slightly better.

During the fourth wave of Covid-19, when many provinces and cities had to implement social distancing, many businesses still achieved capacity from 100% to 120%, even close to 140%; but there are businesses with bad business results, because they have to close, suspend production and the capacity is only 60%-80%.

Businesses that are still doing well say that their salvation is internal factors, speed of response and adaptation, in which, the application of digitalization helps businesses continue to operate, their employees still work from remote locations, and the company can still access the classified data to operate; besides that, the research and development of products; financial potential of the enterprise; the ability to manage risks in the enterprise; increased investment in technology innovation and operational process improvement; marketing activities…

Assessing the growth potential of the pharmaceutical industry in 2022, experts and businesses all believe that the ability to control the disease is still the top factor.

Although the current epidemic is complicated, new strains appear, but with the Government pushing to complete vaccine coverage by the end of 2021, adding a new economic stimulus package, shifting the strategy from "Zero Covid" to "Living safely with the epidemic" under Resolution 128/NQ-CP will help the economy in general and the pharmaceutical industry in particular recover and create growth momentum in 2022.

Source: https://haiquanonline.com.vn/trien-vong-nganh-duoc-nam-2022-duoc-danh-gia-se-tuoi-sang-hon-156879.html